M L Bagarazzi
Overview
Explore the profile of M L Bagarazzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
493
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muthumani K, Kudchodkar S, Zhang D, Bagarazzi M, Kim J, Boyer J, et al.
Vaccine
. 2002 May;
20(15):1999-2003.
PMID: 11983262
Since the first reports of plasmid vaccines, there have been substantial changes made to the design of plasmid backbones, as well as to the antibiotic resistance markers chosen for clinical...
2.
Boyer J, Cohen A, Ugen K, Edgeworth R, Bennett M, Shah A, et al.
AIDS
. 2000 Sep;
14(11):1515-22.
PMID: 10983638
Objective: To assess HIV-1 DNA vaccination and co-immunization with interleukin (IL)-12 and IL-10 as immunotherapy in the HIV-1 infected chimpanzee model system. Methods: Four chimpanzees that were infected with HIV-1-IIIB...
3.
Boyer J, Cohen A, Vogt S, Schumann K, Nath B, Ahn L, et al.
J Infect Dis
. 2000 Feb;
181(2):476-83.
PMID: 10669329
There is a pressing need to test novel vaccine concepts in an effort to develop an effective vaccine for human immunodeficiency virus (HIV) type 1. A phase I clinical study...
4.
Boyer J, Kim J, Ugen K, Cohen A, Ahn L, Schumann K, et al.
Vaccine
. 1999 Oct;
17 Suppl 2:S53-64.
PMID: 10506409
DNA vaccines have a demonstrated ability to induce humoral and cellular immune responses in animal models and humans. The technology, although it dates back to the 1950's, has had an...
5.
Bagarazzi M, Boyer J, Javadian M, Chattergoon M, Shah A, Cohen A, et al.
J Infect Dis
. 1999 Sep;
180(4):1351-5.
PMID: 10479171
DNA vaccines encoding human immunodeficiency virus type 1 (HIV-1) env/rev and gag/pol were delivered intravaginally (IVAG) and intramuscularly (IM) to 2 pregnant chimpanzees. Vaccination was well tolerated and each chimpanzee...
6.
Boyer J, Chattergoon M, Ugen K, Shah A, Bennett M, Cohen A, et al.
Clin Immunol
. 1999 Jan;
90(1):100-7.
PMID: 9884357
A DNA-based vaccine containing HIV-1 Env and Rev genes was tested for safety and host immune response in 15 HIV-infected asymptomatic patients with CD4-positive lymphocyte counts >/=500/microl of blood and...
7.
Bagarazzi M, Boyer J, Ugen K, Javadian M, Chattergoon M, Shah A, et al.
Vaccine
. 1998 Oct;
16(19):1836-41.
PMID: 9795389
A global effort to control the HIV epidemic is likely to rely heavily on immunization strategies. As our closest genetic relative, the chimpanzee provides the most important model for preclinical...
8.
Kim J, Nottingham L, Wilson D, Bagarazzi M, Tsai A, MORRISON L, et al.
Vaccine
. 1998 Oct;
16(19):1828-35.
PMID: 9795388
DNA immunization has been investigated as a potential immunization strategy against infectious diseases and cancer. To enhance a DNA vaccine's ability to induce CTL response in vivo, we co-administered CD80...
9.
Ugen K, Nyland S, Boyer J, Vidal C, Lera L, Rasheid S, et al.
Vaccine
. 1998 Oct;
16(19):1818-21.
PMID: 9795386
Humoral and cellular immune responses have been produced by intramuscular vaccination with DNA plasmids expressing HIV-1 genes, suggesting possible immunotherapeutic and prophylactic value for these constructs. Vaccination with these constructs...
10.
MacGregor R, Boyer J, Ugen K, Lacy K, Gluckman S, Bagarazzi M, et al.
J Infect Dis
. 1998 Jul;
178(1):92-100.
PMID: 9652427
A DNA-based vaccine containing human immunodeficiency virus type 1 (HIV-1) env and rev genes was tested for safety and host immune response in 15 asymptomatic HIV-infected patients who were not...